Alendomax is used to treat osteoporosis in postmenopausal women. It is also effective in treating Paget disease of bone in both men and women. It contains the active ingredient alendronate, which indirectly increases bone mineral density.
Information about Alendomax
- Drug category: Orthopedics
- Drug classification: Bisphosphonate
- Active ingredient: Alendronate
- Indications: Treatment of osteoporosis in postmenopausal women